SyntheticMR AB (SYNT) Stock Analysis | Price, Returns, Financials & Key Metrics

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Dashboard

Unrated Stock - No Analysis Available

Mojo Parameters

Stock DNA

Industry

Pharmaceuticals & Biotechnology

Market cap

SEK 135 Million (Micro Cap)

P/E

NA (Loss Making)

Industry P/E

Dividend Yield

0.00%

Debt Equity

-0.10

Return on Equity

-25.30%

Price to Book

1.00

Revenue and Profits:

Net Sales:

14 Million

(Quarterly Results - Mar 2025)

Net Profit:

-13 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

-56.27%

6 Months

-64.94%

1 Year

-72.25%

2 Years

-94.5%

3 Years

-96.18%

4 Years

-97.85%

5 Years

-96.17%

SyntheticMR AB for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

3.17%

EBIT Growth (5y)

-244.13%

EBIT to Interest (avg)

2.77

Debt to EBITDA (avg)

Net Debt to Equity (avg)

-0.12

Sales to Capital Employed (avg)

0.63

Tax Ratio

2.16%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

9.69%

ROE (avg)

6.12%

Valuation key factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

1.04

EV to EBIT

-4.63

EV to EBITDA

-7.03

EV to Capital Employed

1.05

EV to Sales

2.41

PEG Ratio

Dividend Yield

ROCE (Latest)

-22.56%

ROE (Latest)

-25.30%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Bearish

Mildly Bullish

RSI

No Signal

Bullish

Bollinger Bands

Bearish

Moving Averages

Bearish (Daily)

KST

Bearish

Dow Theory

Mildly Bearish

OBV

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot

No data for shareholding present.

Shareholding Compare (%holding)

No data for shareholding present.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Mar 2025 is -20.22% vs 10.56% in Mar 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Mar 2025 is -491.18% vs 254.55% in Mar 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "Mar'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "14.20",
          "val2": "17.80",
          "chgp": "-20.22%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-5.40",
          "val2": "1.00",
          "chgp": "-640.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "3.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-13.30",
          "val2": "3.40",
          "chgp": "-491.18%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-590.50%",
          "val2": "-37.30%",
          "chgp": "-55.32%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is -37.56% vs 30.60% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is -261.00% vs 69.49% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "55.70",
          "val2": "89.20",
          "chgp": "-37.56%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-18.50",
          "val2": "16.40",
          "chgp": "-212.80%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.10",
          "val2": "0.10",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-16.10",
          "val2": "10.00",
          "chgp": "-261.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-355.90%",
          "val2": "168.00%",
          "chgp": "-52.39%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'25 - YoY

Mar'25

Mar'24

Change(%)

Net Sales

14.20

17.80

-20.22%

Operating Profit (PBDIT) excl Other Income

-5.40

1.00

-640.00%

Interest

3.00

0.00

Exceptional Items

0.00

Consolidate Net Profit

-13.30

3.40

-491.18%

Operating Profit Margin (Excl OI)

-590.50%

-37.30%

-55.32%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Mar 2025 is -20.22% vs 10.56% in Mar 2024

Consolidated Net Profit

YoY Growth in quarter ended Mar 2025 is -491.18% vs 254.55% in Mar 2024

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'24

Dec'24

Dec'23

Change(%)

Net Sales

55.70

89.20

-37.56%

Operating Profit (PBDIT) excl Other Income

-18.50

16.40

-212.80%

Interest

0.10

Exceptional Items

0.00

Consolidate Net Profit

-16.10

10.00

-261.00%

Operating Profit Margin (Excl OI)

-355.90%

168.00%

-52.39%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2024 is -37.56% vs 30.60% in Dec 2023

Consolidated Net Profit

YoY Growth in year ended Dec 2024 is -261.00% vs 69.49% in Dec 2023

All Annual Results

Company CV

About SyntheticMR AB

SyntheticMR AB

Pharmaceuticals & Biotechnology

SyntheticMR AB (publ) is a Sweden-based company that develops and markets software solutions for Magnetic Resonance Imaging (MRI). The Company provides SyMRI, which measures the absolute properties of the brain and delivers adjustable contrast images, automatic biomarker segmentation and quantitative data in a single MR scan. The SyMRI product is available in different packages. SyMRI IMAGE provides fast MRI workflows, allowing high patient throughput. SyMRI NEURO enables automatic segmentation of brain tissue, providing objective decision support. SyMRI Research Edition includes exportable SyMaps, parametric common contrast weighted images and maps of the brain, allowing the investigation to be taken even further. SyMRI is a registered trademark in Europe and in the USA.

Company Coordinates

Company Details

Storgatan 11 , LINKOPING None : 582 23

Tel: 46 13 101650

http://www.syntheticmr.com

Registrar Details